SightfileU.S. market data from official filings

Unicycive Therapeutics Inc (UNCY)

Name: Unicycive Therapeutics Inc (UNCY) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001766140 · EDGAR filings · Updated 2026-07-28

Unicycive Therapeutics Inc (UNCY) has reported institutional ownership of 39.3%, with 51 institutional managers holding positions valued at $65.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

39.3%

Institutional managers

Reported 13F value

$65.2M

Insider activity

1 trans.

$0 net flat

Data flags

2 active

from SEC filings

Filings this week (2)

2026-07-28 — 4/A filed
2026-07-28 — 4/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-08 — SCHEDULE 13G/A filed
2026-07-02 — Current report (8-K) filed
2026-07-01 — Notice of proposed sale filed (Form 144)
2026-06-22 — DEFA14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Unicycive Therapeutics Inc has 51 institutional holders and institutional ownership of 39.3%.

Insider activity

Insiders reported 1 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2022-03-31) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-07-15 (recurring since 2022-08-08) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SAGIMET BIOSCIENCES INC (SGMT) · AC IMMUNE SA (ACIU) · LEONABIO INC (LONA) · LIFEMD (LFMD) · HUTCHMED CHINA LTD (HCM) · Achieve Life Sciences Inc (ACHV)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.